Prognostic factors of anaplastic thyroid carcinoma

Journal of Endocrinological Investigation

Volumn 29, Issue 1, 2006, Pages 11-17

  Jiang, J Y ^a   Tseng, F Y ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anaplastic thyroid carcinoma; Prognostic factors; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; LIOTHYRONINE; THYROXINE; VINCRISTINE SULFATE;

ADULT; AGED; ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HYPOALBUMINEMIA; HYPOTHYROIDISM; KAPLAN MEIER METHOD; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TAIWAN; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

EID: 33644817420     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349171     Document Type: Review

References (43)

1. Figge J. Epidemiology of thyroid cancer. In: Wartofsky L. ed. Thyroid Cancer: a comprehensive guide to clinical management. Totowa: Humana Press. 1999, 77-83.
2. Demeter JG, DeJong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery 1991, 110:956-63.
3. Tan RK, Finley RK 3rd, Driscoll D, Bakamijan V, Hicks WL Jr, Shedd DP. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 1995, 17:41-7.
4. Tobler A, Maurer R, Hedinger CE. Undifferentiated thyroid tumors of diffuse small cell type. Virchows Arch A Pathol Anat Histopathol 1984, 404:117-26.
5. Myskow MW, Krajewski AS, Dewar AE, Millar EP, McLaren K, Fabre JW. The role of immunoperoxidase techniques on paraffin-embedded tissue in determining the histogenesis of undifferentiated thyroid neoplasms. Clin Endocrinol (Oxf) 1986, 24:335-41.
6. Holting T, Moller P, Tschahargane C, Meybier H, Buhr H, Herfarth C. Immuno-histochemical reclassification of anaplastic thyroid carcinoma reveals small and giant cell lymphoma. World J Surg 1990,14:291-5.
7. Ain KB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 1998, 8: 715-26.
8. Bakiri F, Djemli FK, Mokrane LA, Djidel FK. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer 1998, 82: 1146-53.
9. Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin Surg Oncol 1999, 16:64-9.
10. Hadar T, Mor C, Shvero J, Levy R, Segal K. Anaplastic carcinoma of the thyroid. Eur J Surg Oncol 1993, 19: 511-6.
11. Agrawal S, Rao RS, Parikh EM, Parikh HK, Borges AM, Sampat MB. Histologic trends in thyroid cancer 1969-1993: A clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid. J Surg Oncol 1996, 63: 251-5.
12. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997, 79: 564-73.
13. Carty SE. Anaplastic thyroid cancer. In: Surgical Endocrinology, 1st ed. Doherty G, Skogeid B eds. Philadelphia: Lippincott Williams & Wilkin. 2001,127-34.
14. Nel CJ, van Heerden JA, Goellner JR, et al. Anaplastic carcinoma of thyroid: a clinicopathologic study of 82 cases. Mayo Clin Proc 1985, 60: 51-8.
15. Venkatesh YS, Ordonez NG, Schultz PN, Hickey RC, Geopfert H, Samaan NA. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 1990, 66: 321-30.
16. Pasieka JL. Anaplastic thyroid cancer. Curr Opin Oncol 2003,15:78-83.
17. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma: A study of 70 cases. Am J Clin Pathol 1985, 83:135-58.
18. Passler C, Scheuba C, Prager G, et al. Anaplastic (undifferentiated) thyroid carcinoma (ATC). Langenbecks; Arch Surg 1999,384:284-93.
19. American Joint Committee on Cancer. In: Fleming ID, et al. eds. American Joint Committee on Cancer manual for staging of cancer, 5th ed. Philadelphia: Lippincott-Raven 1997.
20. Nilsson 0, Lindeberg J, Zedenius J, et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg 1998, 22: 725-30.
21. Rosai J, Saxen EA, Woolner L. Session III. Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 1985,2:123-36.
22. Sniezek JC , Holtel M. Rare tumors of the thyroid gland. Otolaryngol Clin North Am 2003,36:107-15.
23. Samaan NA, Ordonez NG. Uncommon types of thyroid cancer. Endocrinol Metab Clin North Am 1990,19:637-48.
24. Wolf BC, Sheahan K, DeCoste D, Variakojis D, Alpern HD, Haselow RE. Immunohistochemical analysis of small cell tumors of the thyroid gland: an Eastern Cooperative Oncology Group study. Hum Pathol 1992,23:1252-61.
25. McIver B, Hay ID, Giuffrida D, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001,130:1028-34.
26. Junor EJ, Paul J, Reed NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eurp J Surg Oncol 1992,18:83-8.
27. Burman KD, Ringel MD, Wartofsky L Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am 1996,25:49-68.
28. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998, 83: 2638-48.
29. Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of thyroid. Am J Surg 1999,177:337-9.
30. Chang TC, Liaw KY, Kuo SH, Chang CC, Chen FW. Anaplastic thyroid carcinoma: Review of 24 cases, with emphasis on cytodiagnosis and leukocytosis. J Formosan Med Assoc 1989,88:551-6.
31. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. Prognostic factors and therapeutic strategyfor anaplastic thyroid carcinoma of the thyroid. World J Surg 2001, 25: 617-22.
32. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factors (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986,163:1433-50.
33. Klebanoff SJ, Vadas MA, Harlan JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol 1986,136:4220-5.
34. Zucali JR, Dinarello CA, Oblon DJ, Gross MA, Anderson L, Weiner RS. Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Cin Invest 1986, 77:1857-63.
35. Oppencheim A, Miller M, Anderson GH, Davis B, Slagle T Anaplastic thyroid cancer presenting with hyperthyroidism. Am J Med 1983, 75: 702-4.
36. Murakami T, Noguchi S, Murakami N, Tajiri J, Ohta Y. Destructive thyrotoxicosis in a patient with anaplastic thyroid cancer. Endocrinol Jpn 1989, 36: 905-7.
37. Alagol F, Tanakol R, Boztepe H, Kapran Y, Terzioglu T, Dizdaroglu F. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review. Thyroid 1999, 9:1029-32.
38. Basaria S, Udelsman R, Tejedor-Sojo J, Westra WH, Krasner AS. Anaplastic pseudothyroiditis. Clin Endocrinol (Oxf) 2002,56:553-5.
39. Francis SG, David GG. Basic & Clinical Endocrinology, 7th ed. Lange Medical Books/McGraw-Hill. 2004,215-29.
40. Kobayashi T, Asakawa H, Umeshita K, et al. Treatment of 37 patients with anaplastic thyroid carcinoma of the thyroid. Head Neck 1996,18:36-41.
41. Giuffrida D, Gharib H. Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 2000,11: 1083-9.
42. Tennvall J, Lundell G, Hallquist A, et al. Combined doxorubicin, hyperfradionated radiotherapy and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 1994,74:1348-54.
43. Haigh PI, Ituarte PH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 2001, 91: 2335-42.